← Back to portfolio
Assessed 2026-07-06

TaPIR pRED

Biologics Registration · CSCoE / DDC / Molecular Modality
Lead
Clemens Wrzodek
SMEs
Ralf Fick Dominik Weitl
Provider org
CSCoE / DDC / Molecular Modality

Overall coverage

Modern
66% 100 / 140 points
Coverage = unweighted mean of the 10 dimension coverages (not points ÷ max)

Maturity distribution

Modern 7Transitional 1Tech Debt 2

Coverage vs. portfolio

app vs. avg (dashed)

Score vs. gap by dimension

Prioritized remediation

No recommendations recorded.

Per-question assessment

click a dimension to expand · colored answer chips
FAIR & Discoverability 0 gaps 95%
The dataset or system is findable in a searchable catalog or inventory (e.g., ).
Yes
A named data owner or steward is formally assigned and documented.
Yes
Access and usage conditions, including legal and compliance constraints, are documented and available to users.
Yes
What is the percentage of the data uses standardized terminologies such as RTiS.
50-90%
Data lineage is captured for key data flows and is maintained over time.
Automated
IAM, Privacy & Security 2 gaps 67%
The system uses the approved corporate identity provider for user authentication (e.g., Roche SSO via PingFederate, OAuth 2.0, OpenID Connect).
Yes
Data is encrypted in transit.
Yes
Data is encrypted at rest.
No
Secrets are managed in an approved central vault (e.g., HashiCorp Vault or AWS Secrets Manager).
Yes
Access rights and permissions are reviewed and formally certified at defined intervals.
Yes
No shared or generic privileged accounts exist in the production environment.
No
Platform / Hosting / Infrastructure 2 gaps 0%
Infrastructure is provisioned declaratively using Infrastructure as Code.
No
The system uses approved shared internal platforms or Golden Paths, where applicable. (e.g., Minerva Application Blueprint)
No
Architecture & Interoperability 0 gaps 100%
Can we swap in and out components without modifying the system.
Yes
All application services are exposed through clear and defined interfaces.
Yes
APIs, events, and data contracts are documented and governed.
Yes
API lifecycle management is actively implemented using Gravitee.
Yes
Reliability 1 gap 67%
All critical services have defined SLAs and SLOs.
Yes
Major incidents are followed by systematic postmortems, and resulting corrective actions are tracked to closure in the backlog.
Yes
SLIs are defined and calculated for all established SLAs and SLOs, and are visible to stakeholders and system owners.
No
Scalability & Performance 2 gaps 25%
The system supports automated vertical and horizontal scaling based on real-time demand, where applicable.
No
Load and performance testing are performed routinely and included in major release cycles.
Partial
Deployment Automation 2 gaps 70%
Core workloads are supported by a complete CI/CD pipeline.
Partial
Builds, tests, and deployments are executed through fully automated processes.
Yes
Automated quality gates are enforced before production deployment. (e.g., SonarQube)
Yes
Production rollback or deployment occurs regularly and within the last 6 months.
No
Build artifacts and dependencies are managed in a traceable and controlled manner.
Yes
Observability 3 gaps 50%
All critical services generate standard telemetry, including logs, metrics, and traces.
Partial
Observability data is available through approved central monitoring and observability tools.
Partial
Incident analysis can be performed across upstream and downstream dependencies.
Partial
Resilience & Recovery 0 gaps 100%
Critical services and data have defined Recovery Time Objective (RTO) and Recovery Point Objective (RPO) targets.
Yes
Backup, restore, and recovery procedures, including assigned roles and responsibilities, are documented and tested.
Yes
Cost Transparency & FinOps 0 gaps 92%
Cost visibility is available at component, system, product family, or domain level.
System
Cost is reviewed regularly together with usage and business value by the owning team.
Yes
Architectural decisions explicitly consider cost as a primary decision variable.
Yes